ChartMill assigns a Buy % Consensus number of 87% to KALV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | Needham | Maintains | Buy -> Buy |
| 2026-01-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-06 | Needham | Maintains | Buy -> Buy |
| 2025-12-04 | Needham | Reiterate | Buy -> Buy |
| 2025-11-11 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-09-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-09-12 | Needham | Reiterate | Buy -> Buy |
| 2025-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-07-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-07 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-03-26 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-26 | Jones Trading | Maintains | Buy -> Buy |
| 2025-03-26 | Needham | Reiterate | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | Needham | Reiterate | Buy -> Buy |
| 2025-03-03 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-31 | JMP Securities | Initiate | Market Outperform |
| 2025-01-07 | TD Cowen | Initiate | Buy |
| 2024-12-18 | B of A Securities | Initiate | Buy |
| 2024-12-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-05 | Needham | Reiterate | Buy -> Buy |
| 2024-10-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-27 | Jones Trading | Initiate | Buy |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-06 | Needham | Reiterate | Buy -> Buy |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
15 analysts have analysed KALV and the average price target is 33.89 USD. This implies a price increase of 121.34% is expected in the next year compared to the current price of 15.31.
The consensus rating for KALVISTA PHARMACEUTICALS INC (KALV) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.